Clinical Trial Update: Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing finafloxacin 300 mg twice daily with ciprofloxacin 250 mg twice daily in patients with lower uncomplicated urinary tract infection has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Urinary Tract Infection
• Urinary Tract Infection

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Finafloxacin (finafloxacin)

Snippet

Sponsor: MerLion Pharmaceuticals GmbH | Conditions: Urinary Tract Infections | Phase 2 | Status: COMPLETED